Cosmos Health Inc. (COSM)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NASDAQ
Market Cap: $12.53M
Last updated: Nov 17, 2026 at 4:34 PM ET
Cosmos Health Inc. (COSM) Statistics
Cosmos Health (COSM) has a market cap of $12.53M and an enterprise value of $26.07M. Its share count is down 89.58% from a year earlier. Revenue grew 33.82% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 108.05% above the market cap, as debt exceeds cash.
| Market Cap | $12.53M |
|---|---|
| Enterprise Value | $26.07M |
| Latest price (Nov 17, 2026) | $2.85 |
Key Dates
The next earnings report is expected on Apr 13, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Apr 13, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.1x and 0.4x. Its year-end P/S ranged from 82.8x to 675.2x from 2016 to 2024.
| P/S Ratio | 0.1x |
|---|---|
| Forward P/S | 0.1x |
| P/B Ratio | 0.4x |
| P/TBV Ratio | 0.7x |
Price Statistics
The stock is down 80.27% over 52 weeks and trades 52.66% below its 50-day average.
| Beta (1Y) | 1.71 |
|---|---|
| 52-Week Change | -80.27% |
| 1-Month Change | -56.15% |
| 3-Month Change | -26.17% |
| 6-Month Change | -49.56% |
| 5-Year Change | -99.70% |
| 10-Year Change | -98.08% |
| Total Return (1Y) | -80.27% |
| Total Return (3Y CAGR) | -49.08% |
| Total Return (5Y CAGR) | -73.35% |
| Return vs SPY (1Y) | -91.20% |
| Max Drawdown (1Y) | -82.22% |
| Max Drawdown (3Y) | -91.86% |
| Sharpe Ratio (1Y) | -1.44 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $6.02 |
| 200-Day Average | $5.91 |
| 52-Week Range | $2.46 to $14.37 |
| RSI (14 Days) | 33.8 |
| Average Volume (20 Days) | 2.15M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.05x current liabilities, and total debt is 0.74x shareholder equity.
| Current Ratio | 1.05x |
|---|---|
| Quick Ratio | 0.92x |
| Debt / Equity | 0.74x |
| Interest Coverage | -5.97x |
Returns and Efficiency
Return on invested capital is -45.83% over the last 12 months, against a 5-year average of -22.80%.
| Return on Equity (ROE) | -117.98% |
|---|---|
| Return on Assets (ROA) | -39.68% |
| Return on Invested Capital (ROIC) | -45.83% |
| Return on Capital Employed (ROCE) | -78.48% |
| ROE (5Y Average) | -87.60% |
| ROA (5Y Average) | -24.71% |
| ROIC (5Y Average) | -22.80% |
| Asset Turnover | 1.20x |
| Inventory Turnover | 13.01x |
| Receivables Turnover | 3.38x |
| Cash Conversion Cycle | 58 days |
Scores
COSM has an Altman Z-Score of -3.00, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -3.00 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $73.73M over the last 12 months.
| Revenue | $73.73M |
|---|---|
| Revenue Growth (YoY) | +33.82% |
| Gross Profit | $7.57M |
| Operating Income | -$18.17M |
| Pretax Income | -$24.39M |
| Net Income | -$24.39M |
| EBIT | -$20.89M |
| Reported EPS (TTM) | -$11.07 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 33.63% of the $61.46M in total assets.
| Cash and Equivalents | $1.80M |
|---|---|
| Total Debt | $15.34M |
| Net Debt | $13.54M |
| Net Debt Per Share | $4.52 |
| Working Capital | $1.83M |
| Shareholder Equity | $20.67M |
| Book Value Per Share | $6.90 |
| Tangible Book Value | $12.04M |
| Tangible Book Per Share | $4.02 |
| Total Assets | $61.46M |
| Total Liabilities | $40.79M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $95.80K of capital spending, operating cash flow left -$11.45M of free cash flow.
| Operating Cash Flow | -$11.35M |
|---|---|
| Capital Expenditures | $95.80K |
| Free Cash Flow | -$11.45M |
| FCF Per Share | -$2.28 |
| Depreciation and Amortization | $1.39M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -24.65%, against a 5-year average of -23.54%.
| Gross Margin | 10.27% |
|---|---|
| Operating Margin | -24.65% |
| Pretax Margin | -33.08% |
| Net Margin | -33.08% |
| EBIT Margin | -28.34% |
| FCF Margin | -15.53% |
| Gross Margin (5Y Average) | 10.96% |
| Operating Margin (5Y Average) | -23.54% |
| Net Margin (5Y Average) | -27.09% |
Growth
Revenue grew 9.04% a year over 3 years.
| Revenue Growth (3Y CAGR) | +9.04% |
|---|---|
| Revenue Growth (5Y CAGR) | +3.33% |
| Book Value Per Share Growth (2Y CAGR) | -55.52% |
| Tangible Book Per Share Growth (2Y CAGR) | -61.51% |
Dividends and Yields
COSM does not pay a dividend. Its free cash flow yield is -134.08%.
| FCF Yield | -134.08% |
|---|---|
| Shareholder Yield | 150.64% |
Stock Splits
The last split was a 1-for-20 reverse split on Nov 13, 2026.
| Last Split Date | Nov 13, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Peer Position
Against 6 similar companies, COSM has the lowest P/S.
P/S RatioPeer median 5.9x
ROICPeer median -40.48%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -19.76%
| P/S Ratio | 0.1x vs 5.9x median |
|---|---|
| ROIC | -45.83% vs -40.48% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +33.82% vs -19.76% median |
Analyst Forecast
Consensus estimates put revenue growth at 40.91% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +40.91% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About COSM
What is COSM's market cap?
Cosmos Health has a market cap of $12.53M. Its enterprise value, which adds debt and subtracts cash, is $26.07M.
How many shares of COSM are outstanding?
Cosmos Health has 3.00M shares outstanding. The count is down 89.58% from a year earlier.
Does COSM pay a dividend?
No. Cosmos Health does not pay a dividend.
How much debt does COSM have?
Cosmos Health has $15.34M of total debt and $1.80M of cash and equivalents, a net debt position of $13.54M.
COSM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors